why do you need to stop glp 1 before surgery Stopping GLP-1 RAs 14 days can minimize complications Why can't diabetics take GLPs

(Source: illumina.com) November 2024: Ascendis Pharma licensed its TransCon technology to Novo Nordisk for metabolic and cardiovascular drug development, including a monthly GLP-1 agonist for obesity and diabetes

Campisi J, Kapahi P, Lithgow GJ, Melov S, Newman JC, Verdin E

Book in for a consultation at one of our clinics in Sydney, Brisbane or the Gold Coast today.

We're committed to providing you with the most effective, personalized care for sustainable weight loss because we believe you deserve: Significant reduction in hunger and cravings for easier portion control Expert management of weight-related conditions like diabetes, hypertension, and joint pain Convenient weekly injections with minimal disruption to your daily routine Preservation of muscle mass while targeting stubborn fat deposits Improved metabolic health and increased energy levels Reduced reliance on multiple medications for obesity-related conditions Comprehensive support from initial consultation through your entire weight loss journey Dr